期刊文献+

Rho激酶抑制剂对膀胱癌细胞侵袭能力的影响 被引量:3

Effect of Rho kinase inhibitor on the invasive ability of bladder cancer
下载PDF
导出
摘要 目的:探讨Rho激酶抑制剂对体外培养的膀胱癌细胞侵袭能力的影响。方法:培养膀胱癌细胞株T24,采用CCK-8实验、体外细胞侵袭实验、细胞运动实验测Rho激酶抑制剂对细胞生长和侵袭运动能力的影响。结果:经Rho激酶抑制剂处理后的膀胱癌细胞株T24的侵袭和运动能力明显下降,呈浓度依赖性,且当药物浓度>75μmol/L后,细胞的生长受到明显的抑制。结论:Rho激酶信号转导系统对膀胱癌细胞的侵袭和生长有重要的影响。 Objective: To probe the effect of Rho kinase inhibitor on the invasive ability of bladder cancer.Methods: bladder cancer cell line T24 was cultured,CCK-8 experiments,in vitro invasion assay and cell movement experiment were used to measure the changes of the growth,movement and the invasion ability of bladder cancer when Rho kinase was inhibited before and after.Results: After treatment with Rho kinase inhibitor,the growth,invasion and movement of bladder cancer cells line T24 were inhibited obviously,and these were decreasing along with the increasing inhibited degree of the Rho kinase.And when the drug concentration 75 umol / L,the cell growth was inhibited obviously.Conclusion: Rho kinase signaling pathway importantly affects the cell invasion and growth of bladder cancer.
出处 《温州医学院学报》 CAS 2011年第5期459-461,共3页 Journal of Wenzhou Medical College
关键词 膀胱肿瘤 RHO激酶抑制剂 细胞侵袭 bladder cancer rho kinase inhibitor cell invasion
  • 相关文献

参考文献10

  • 1Nakajima M,Hayashi K,Eqi Y,et al.Effect of Wf-536,a novel ROCK inhibitor,against metastasis of B16 melanoma[J].Cancer Chemoth Pharm,2003,52(4):319-324.
  • 2Jemal A,Brcy F,Center MM,et al.Global cancer statistics[J].CA-Cancer J Clin,2011,61(2):69-90.
  • 3Gomez del Pulqar T,Benitah SA,Valeron PF,et al.Rho GTPase expression in tumourigenesis:evidence for a sig-nificant link[J].Bio essays,2005,27(6):602-613.
  • 4Matsui T,Amano M,Yamamoto T,et al.Rho-associated kinase,a novel serine / threonine kinase,as a putative target for small GTP binding protein Rho[J].EMBO J,1996,15(9):J2208-2216.
  • 5Mueller BK,Mack H,Teusch N.Rho kinase,a promising drug target for neurological disorders[J].Nat Rev Drug Discov,2005,4(5):387-398.
  • 6Zheng R,Iwase A,Shen R,et al.Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase[J].Oncogene,2006,25(44):5942-5952.
  • 7马健,杨罗艳,吴洪涛,谭孝其.膀胱癌组织中Rock-2和MMP-2的表达及相互关系的研究[J].中外健康文摘:医药月刊,2007,4(5):51-53. 被引量:2
  • 8Kawanishi H,Matsui Y,Ito M,et al.Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer[J].Clin Cancer Res,2008,14(9):2579-2587.
  • 9Villalonga P,Ridley AJ.Rho GTPases and cell cycle control[J].Growth Factors,2006,24(3):159-164.
  • 10Loirand G,Guerin P,Pacaud P.Rho kinases in cardiovascu-lar physiology and pathophysiology[J].Circ Res,2006,98 (3):322-334.

共引文献1

同被引文献38

  • 1戴玉田,孙则禹,Chitaley K,Webb RC,Mills TM,Lewis RW.应用Rho激酶抑制剂对大鼠阴茎勃起的作用[J].中华男科学杂志,2004,10(8):589-592. 被引量:5
  • 2王德盛,窦科峰,李开宗,宋振顺,赵青川.Rho/Rho激酶对肝癌细胞体外侵袭转移作用的研究[J].中华普通外科杂志,2005,20(4):245-247. 被引量:7
  • 3Yoshimura H, Matsuda Y, Naito Z, et al. Ultra-high-resolu- tion images of nestin and vimentin in pancreatic carcinoma cells using 2 novel microscopy systems[J]. J Nippon Med Sch, 2012, 79(6): 392-393.
  • 4Zhang SN, Huang FT, Huang Y J, et al. Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells[J]. Tumori, 2010, 96(6): 985-992.
  • 5Park GB, Kim YS, Song H, et al. Cross-linking of CD80 and CD86 diminishes expression of CD54 on EBV-transformed B cells through inactivation of RhoA and Ras[J]. Immune Netw, 2011, 11(6): 390-398.
  • 6David M, Petit D, Bertoglio J. Cell cycle regulation of Rho signaling pathways[J]. Cell Cycle, 2012, 11(16): 3003-3010.
  • 7Chang YW, Bean RR, Jakobi R. Targeting RhoA/Rho kinase and p2 1-activated kinase signaling to prevent cancer devel-opment and progress]J]. Recent Pat Anticancer Drug Discov, 2009, 4(2): 110-124.
  • 8Ariake K, Ohtsuka H, Motoi F, et al. GCF2/LRRFIP1 pro- motes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation[J]. Cancer Lett, 2012, 325(1): 99-107.
  • 9Gen Y, Yasui K, Zen K, et al. A novel amplification target, ARHGAP5, promotes cell spreading and migration by nega- tively regulating RhoA in Huh-7 hepatocellular carcinoma cells[J]. Cancer Lett, 2009, 275(1): 27-34.
  • 10Croucher DR, Rickwood D, Tactacan CM, et al. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 1 1q 13-amplified head and neck squamous cell carcinoma cells[J]. Mol Cell Biol, 2010, 30(21): 5057-5070.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部